The Patent Finder

VLP Biotech, Inc.

Also on record
Records under this name other than the patents VLP Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 4 of 4 · Back to VLP Biotech, Inc.

PatentTitleStatus Expires Confidence
US 7,144,712Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
Term ended
Term ended Nov 20, 2023 · From the USPTO record
Term endedTerm ended Nov 20, 2023From the USPTO record
US 7,320,795Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
Term ended
Term ended Aug 19, 2023 · From the USPTO record
Term endedTerm ended Aug 19, 2023From the USPTO record
US 7,883,843Hepatitis virus core proteins as vaccine platforms and methods of use thereof
Lapsed on the fee record
Ended Feb 8, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 8, 2023From the USPTO record
US 7,811,576Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
Lapsed on the fee record
Ended Oct 12, 2022 · From the USPTO record
Lapsed on the fee recordEnded Oct 12, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited